U.S. Markets close in 53 mins

Sirona Biochem Corp. (SBM.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.2550-0.0100 (-3.77%)
As of 1:42PM EDT. Market open.

Sirona Biochem Corp.

605 – 889 West Pender Street
Vancouver, BC V6C 3B2
Canada
450 332 6939
http://www.sironabiochem.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Dr. Howard J. Verrico Ph.D., M.D.Founder, Chairman, CEO & Sec.245.2kN/A1961
Mr. Christopher D. HoptonCFO & Director212.6kN/A1966
Dr. Géraldine Deliencourt-GodefroyChief Scientific Officer & Director252.39kN/AN/A
Ms. Michelle Seltenrich MBAVP of OperationsN/AN/AN/A
Dr. Brett A. Premack Ph.D.Scientific ConsultantN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Sirona Biochem Corp. develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. The company develops programs in the areas of diabetes, anti-inflammatories, and anti-infectives for therapeutics; anti-aging and depigmenting agents in cosmeceuticals; and biological ingredients, such as inducers and adjuvants for the biological development and preservation. It develops a sodium glucose co-transporter inhibitor for the treatment of diabetes, as well as cosmetic skin lightening agents and compounds. The company was formerly known as High Rider Capital Inc. and changed its name to Sirona Biochem Corp. in May 2009. Sirona Biochem Corp. was incorporated in 2006 and is headquartered in Vancouver, Canada.

Corporate Governance

Sirona Biochem Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.